“This program further validates the 23andMe database as a proven resource for identifying novel therapeutic targets,” said Jennifer Low, Head of Therapeutics Development, 23andMe. “The team is excited to initiate our next immuno-oncolo...
53 Fed.Reg. 11983. The details and extent of any revisions, however, is unclear at this time, as is the degree to which the revised program actually complies with the
In addition to surgical excision and local radiotherapy, cytotoxic chemotherapy still serves as the first-line therapy for most cancer patients but has reached a therapeutic plateau [2]. To address the gaps in cancer care, effective and evidence-based curative interventions need to be tailored for...
are the guarantors of this work and, as such, have full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors critically revised and approved the final version the manuscript. Additional Information ...
E-mail: kmasuo@baker.edu.au Received May 25, 2006; Accepted in revised form August 9, 2006. 952 Hypertens Res Vol. 29, No. 12 (2006) Table 1. Characteristics of Obese Normotensive Subjects at Entry and at Year 5 With BP elevation Without BP elevation Variable With weight gain Without ...
So of course I revised my description telling how great it worked. The MAN then told me he had 400 toasters. That he thought the Toaster would go over $1000. I was happy! Told me how Rare it was--that he was going to his office to watch and bid on it. I knew this was THE ...
are described from time to time in the Company’s filings with the Securities and Exchange Commission, including under Item 1A, “Risk Factors” in the Company’s most recent Annual Report on Form 10-K, as filed with the Securities ...